[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337825-105":59,"doc-detail-337825-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","association-of-the-shox2-and-rassf1a-methylation-levels-with-the-pathological-evolution-of-early-stage-lung-adenocarcinoma","Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma","","Methylation of SHOX2 and RASSF1A is evaluated as a potential biomarker to support early screening and improve the limitations of morphology-based diagnosis for lung cancer. The study measures SHOX2 and RASSF1A methylation levels and uses them for diagnostic assessment of lung adenocarcinoma, aiming to predict invasiveness before surgery. Methylation is quantified by methylation-specific PCR using a LungMe® test kit, with ROC analysis and regression models determining diagnostic performance and hazardous factors. Cutoff values are 8.3 and 12.0, and combined methylation correlates with key clinicopathological features and invasiveness.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-the-shox2-and-rassf1a-methylation-levels-with-the-pathological-evolution-of-early-stage-lung-adenocarcinoma/337825/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-the-shox2-and-rassf1a-methylation-levels-with-the-pathological-evolution-of-early-stage-lung-adenocarcinoma/337825.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of measuring SHOX2 and RASSF1A methylation in lung adenocarcinoma?","Question",{"text":112,"@type":113},"To use methylation levels of SHOX2 and RASSF1A as biomarkers for early screening and to provide an accurate pathological diagnosis that helps predict invasiveness before surgery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were SHOX2 and RASSF1A methylation levels quantified?",{"text":117,"@type":113},"They were quantified using a LungMe® test kit via methylation-specific PCR (MS-PCR).",{"name":119,"@type":110,"acceptedAnswer":120},"What factors were associated with invasiveness in the study?",{"text":121,"@type":113},"SHOX2 and RASSF1A methylation levels and LungMe® showed correlations with invasiveness-related clinicopathological features such as age, gender, tumor size, TNM stage, pathological type, pleural invasion, and STAS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337825,1790662766,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Zhao et al. BMC Cancer (2024) 24:687 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12452-x](https://doi.org/10.1186/s12885-024-12452-x)  \nRESEARCH Open Access  \nAssociation of the SHOX2 and RASSF1Amethylation levels with the pathological evolution of early-stage lung adenocarcinoma  \nJiaping Zhao 1,2, Yu Lu 1,2, Xiaosha Ren3, Tingting Bian4, Jia Feng4, Hui Sun4, Lei Liu4, Bin She3,4,5, Yifei Liu4* and Honggang Ke 1*  \nAbstract  \nBackground The methylation of SHOX2 and RASSF1A shows promise as a potential biomarker for the early screening of lung cancer, offering a solution to remedy the limitations of morphological diagnosis. The aim of this study is to diagnose lung adenocarcinoma by measuring the methylation levels of SHOX2 and RASSF1A, and provide an accurate pathological diagnosis to predict the invasiveness of lung cancer prior to surgery.  \nMaterial and methods The methylation levels of SHOX2 and RASSF1A were quantified using a LungMe® test kit through methylation-specific PCR (MS-PCR) . The diagnostic efficacy of SHOX2 and RASSF1A and the cutoff values were validated using ROC curve analysis. The hazardous factors influencing the invasiveness of lung adenocarcinoma were calculated using multiple regression.  \nResults: The cutoff values of SHOX2 and RASSF1A were 8.3 and 12. 0, respectively. The sensitivities of LungMe® in IA, MIA and AIS patients were 71. 3%(122/171), 41. 7%(15/36), and 16. 1%(5/31) under the specificity of 94. 1%(32/34) for benign lesions. Additionally, the methylation level of SHOX2, RASSF1A and LungMe® correlated with the high invasiveness of clinicopathological features, such as age, gender, tumor size, TNM stage, pathological type, pleural invasion and STAS. The tumor size, age, CTR values and LungMe® methylation levels were identified as independent hazardous factors influencing the invasiveness of lung adenocarcinoma.  \nConclusion: SHOX2 and RASSF1A combined methylation can be used as an early detection indicator of lung adenocarcinoma. SHOX2 and RASSF1A combined (LungMe®) methylation is significantly correlated to age, gender, tumor size, TNM stage, pathological type, pleural invasion and STAS. The SHOX2 and RASSF1A methylation levels, tumor size and CTR values could predict the invasiveness of the tumor prior to surgery, thereby providing guidance for the surgical procedure.  \nKeywords Lung adenocarcinoma, SHOX2, RASSF1A, Methylation, Invasiveness  \n*Correspondence:  \nYifei Liu [ntdxliuyifei@sina.com](ntdxliuyifei@sina.com)[ ](ntdxliuyifei@sina.com)Honggang Ke [tranquillity_z@163.com](tranquillity_z@163.com)  \n1Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong 226001, Jiangsu, China  \n2Medical School of Nantong University, Nantong University, ChongChuan District, NanTong 226001, Jiangsu, China  \n3Department of Academic Development, Shanghai methyldia technology Co. Ltd, No. 412 Huiqing Road , Shanghai 201203, China  \n4Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District,  \nNanTong 226001, Jiangsu, China  \n5Tellgen Corporation Co. Ltd, No. 115, Lane 572, Bibo Road, Pilot Free Trade Zone, Shanghai 201203, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to","cbCaiqdKvM9JnkXO","https://ap.wps.com/l/cbCaiqdKvM9JnkXO","pdf",2620990,13,"English","# Introduction\n# Abstract\n## Background\n## Material and methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What is the purpose of measuring SHOX2 and RASSF1A methylation in lung adenocarcinoma?\",\"answer\":\"To use methylation levels of SHOX2 and RASSF1A as biomarkers for early screening and to provide an accurate pathological diagnosis that helps predict invasiveness before surgery.\"},{\"question\":\"How were SHOX2 and RASSF1A methylation levels quantified?\",\"answer\":\"They were quantified using a LungMe® test kit via methylation-specific PCR (MS-PCR).\"},{\"question\":\"What factors were associated with invasiveness in the study?\",\"answer\":\"SHOX2 and RASSF1A methylation levels and LungMe® showed correlations with invasiveness-related clinicopathological features such as age, gender, tumor size, TNM stage, pathological type, pleural invasion, and STAS.\"}]","Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma | PDF",1790020813,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2304b7db92b2ed8843baa41072465c0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa21f34ef41d485bca21a4efe2c1b484.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b034018c35b5de29e8cdcf80de4959ac.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b560d3dde7ff63dd9b5decd6267487c.webp",980,1306]